Synthesis and Studies on the Anticonvulsant Activity of 5-alkoxy-[1,2,4]triazolo[4,3-a]pyridine Derivatives

Abstract

In this study, a series of new 5-alkoxy-[1,2,4]triazolo[4,3-a]pyridine derivatives was synthesized and their anticonvulsant activity and neurotoxicity was evaluated with the maximal electroshock and rotarod tests, respectively. The most promising compounds, 3p (5-(4-chlorophenoxy)-[1,2,4]triazolo[4,3-a]pyridine) and 3r (5-(4-bromophenoxy)-[1,2,4]triazolo[4,3-a]pyridine), showed a median effective dose of 13.2 and 15.8 mg/kg and had a protective index value of 4.8 and 6.9, respectively. For exploring the putative mechanism of action, compounds 3n, 3p and 3r were tested in chemically induced models.

Key words

[1,2,4]triazolo[4,3-a]pyridine - synthesis - anticonvulsant activity - chemically induced model

• References

• 1 Loscher W. New visions in the pharmacology of anticonvulsant. Eur J Pharmacol 1998; 342: 1-13
• 2 LeppikI E. Antiepileptic drugs in development: prospects for the near future. Epilepsia 1994; 35 (Suppl. 04) 29-40
• 3 Perucca E. The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 1996; 42: 531-543
• 4 Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004; 5: 553-564
• 5 Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics 2007; 4: 18-61
• 6 Lin Z, Kadaba PK. Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med Res Rev 1997; 17: 537-572
• 7 Al-Soud YA, Al-Masoudi NA, Ferwanah Ael R. Synthesis and properties of new substituted 1,2,4- triazoles: potential antitumor agents. Bioorg Med Chem 2003; 11: 1701-1708
• 8 Sun XY, Guan LP, Zhang L et al. Design, synthesis and anticonvulsant activity evaluation of 7-substituted-4H-[1,2,4]triazino[3,4-a]phthalazin-4-one derivatives. J Braz Chem Soc 2009; 20: 826-831
• 9 Guan LP, Sui X, Deng XQ et al. Synthesis and anticonvulsant activity of a new 6-alkoxy-[1,2,4]triazolo[4,3-b]pyridazine. Eur J Med Chem 2010; 45: 1746-1752
• 10 Zhang L, Guan LP, Sun XY et al. Synthesis and anticonvulsant activity of 6-alkoxy-[1,2,4]triazolo[3,4-a]phthalazines. Chem Biol Drug Des 2009; 73: 313-319
• 11 Krall RL, Penry JK, White BG et al. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978; 19: 409-428
• 12 Porter RJ, Cereghino JJ, Gladding GD et al. Antiepileptic drug development program. Cleve Clin Q 1984; 51: 293-305
• 13 Bernasconi R, Klein M, Martin P et al. comparison of neurochemical and anticonvulsant effects in mice. J Neural Transm 1988; 72: 213-233
• 14 Arnoldi A, Bonsignori A, Melloni P et al. Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2,3-dihydro-4H-1-benzopyrans and -benzothiopyrans. J Med Chem 1990; 33: 2865-2869
• 15 Löscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 1988; 2: 145-181
• 16 Mokrab Y, Bavro VN, Mizuguchi K et al. Exploring ligand recognition and ion flow in comparative models of the human GABA type A receptor. J Mol Graph Model 2007; 26: 760-774
• 17 Okada R, Negishi N, Nagaya H. The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures. Brain Res 1989; 480: 383-387
• 18 Olsen RW. GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 1981; 37: 1-3
• 19 Gale K. GABA and epilepsy: basic concepts from preclinical research. Epilepsia 1992; 33: S3-S12
• 20 Löscher W. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. Biochem Pharmacol 1979; 28: 1397-1407